lu 135252 has been researched along with Acute Respiratory Distress Syndrome in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Boemke, W; Busch, T; Deja, M; Jaghzies, U; Kaisers, U; Petersen, B; Wolf, S | 1 |
| Boemke, W; Busch, T; Deja, M; Donaubauer, B; Kaisers, U; Petersen, B; Skomrock, J; Wolf, S | 1 |
| Janzen, R; Koch, T; Münter, K; Neuhof, H; Schmeck, J | 1 |
3 other study(ies) available for lu 135252 and Acute Respiratory Distress Syndrome
| Article | Year |
|---|---|
The inhaled ET(A) receptor antagonist LU-135252 acts as a selective pulmonary vasodilator.
Topics: Administration, Inhalation; Analysis of Variance; Animals; Blood Pressure; Endothelin Receptor Antagonists; Endothelium, Vascular; Models, Animal; Nitric Oxide; Phenylpropionates; Prospective Studies; Pulmonary Gas Exchange; Pulmonary Veins; Pyrimidines; Random Allocation; Receptor, Endothelin A; Respiratory Distress Syndrome; Statistics, Nonparametric; Swine; Vasodilator Agents | 2002 |
Inhalation of the endothelin-A receptor antagonist LU-135252 at various doses in experimental acute lung injury.
Topics: Administration, Inhalation; Animals; Animals, Newborn; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelin A Receptor Antagonists; Hemodynamics; Nebulizers and Vaporizers; Phenylpropionates; Pulmonary Gas Exchange; Pyrimidines; Receptor, Endothelin A; Respiratory Distress Syndrome; Respiratory System Agents; Swine; Time Factors | 2004 |
Endothelin-1 and thromboxane A2 increase pulmonary vascular resistance in granulocyte-mediated lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Analysis of Variance; Animals; Cyclooxygenase Inhibitors; Diclofenac; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Female; Granulocytes; In Vitro Techniques; Male; N-Formylmethionine Leucyl-Phenylalanine; Perfusion; Phenylpropionates; Prospective Studies; Pulmonary Artery; Pyrimidines; Rabbits; Random Allocation; Respiratory Distress Syndrome; Thromboxane A2; Thromboxane B2; Vascular Resistance | 1998 |